T. Rowe Price Associates’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7K | Hold |
|
|||||
|
2024
Q4 | $18K | Hold |
|
|||||
|
2024
Q3 | $20K | Hold |
|
|||||
|
2024
Q2 | $65K | Sell |
|
|||||
|
2024
Q1 | $2.6M | Sell |
|
|||||
|
2023
Q4 | $8.09M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $304K | Buy |
|
|||||
|
2021
Q2 | $222K | Sell |
|
|||||
|
2021
Q1 | $330K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $8.44M | Buy |
|